This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (63)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Frank Davidoff, MD; Catherine D. DeAngelis, MD,MPH; Jeffrey M. Drazen, MD; John Hoey, MD; Liselotte Højgaard, MD,DMSc; Richard Horton, FRCP; Sheldon Kotzin, MLS; M. Gary Nicholls, MD; Magne Nylenna, MD; A. John P. M. Overbeke, MD,PhD; Harold C. Sox, MD; Martin B. Van Der Weyden, MD,FRACP,FRCPA; Michael S. Wilkes, MD,PhD

JAMA. 2001;286:1232-1234.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As editors of general medical journals, we recognize that the publication of clinical research findings in respected peer-reviewed journals is the ultimate basis for most treatment decisions. Public discourse about this published evidence of efficacy and safety rests on the assumption that clinical trials data have been gathered and are presented in an objective and dispassionate manner. This discourse is vital to the scientific practice of medicine because it shapes treatment decisions made by physicians and drives public and private health care policy. We are concerned that the current intellectual environment in which some clinical research is conceived, study subjects . . . [Full Text of this Article]

Author Affiliations: Dr Davidoff is editor emeritus, Annals of Internal Medicine; Dr DeAngelis is editor, JAMA; Dr Drazen is editor-in-chief, New England Journal of Medicine; Dr Hoey is editor, Canadian Medical Association Journal; Dr Højgaard is editor-in-chief, Tidsskrift for Den norske laegeforening (Journal of the Norwegian Medical Association); Dr Horton is editor, The Lancet; Mr Kotzin is executive editor, MEDLINE/Index Medicus; Dr Nicholls is editor, New Zealand Medical Journal; Dr Nylenna is editor-in-chief, Norwegian Medical Association; Dr Overbeke is executive editor, Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine); Dr Sox is editor, Annals of Internal Medicine; Dr Van Der Weyden is editor, The Medical Journal of Australia; and Dr Wilkes is editor, WJM Western Journal of Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
Nieto et al.
Arch Intern Med 2007;167:2047-2053.
ABSTRACT | FULL TEXT  

Response to Letters by Whiteley et al and Goldstein et al
Weintraub
Stroke 2006;37:2664-2665.
FULL TEXT  

Academic Medical Centers and Medical Research: The Challenges Ahead
Cohen and Siegel
JAMA 2005;294:1367-1372.
ABSTRACT | FULL TEXT  

Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
Fontanarosa et al.
JAMA 2005;294:110-111.
FULL TEXT  

Manufacturing Uncertainty: Contested Science and the Protection of the Public's Health and Environment
Michaels and Monforton
Am. J. Public Health 2005;95:S39-S48.
ABSTRACT | FULL TEXT  

When Health Policy Is the Problem: A Report from the Field
Spitz and Abramson
Journal of Health Politics, Policy and Law 2005;30:327-366.
ABSTRACT  

Changing Conclusions on Secondhand Smoke in a Sudden Infant Death Syndrome Review Funded by the Tobacco Industry
Tong et al.
Pediatrics 2005;115:e356-e366.
ABSTRACT | FULL TEXT  

The commercialization of clinical research: who pays the piper, calls the tune?
Freemantle and Stocken
Fam Pract 2004;21:335-336.
FULL TEXT  

Instructions for Authors
Arch Gen Psychiatry 2004;61:102-102.
FULL TEXT  

Towards a European Network for Multiple Sclerosis Trials (ENMST)
Kappos et al.
Mult Scler 2003;9:627-629.
ABSTRACT  

Instructions for Authors
Arch Gen Psychiatry 2003;60:1056-1056.
FULL TEXT  

Association of Funding and Conclusions in Randomized Drug Trials: A Reflection of Treatment Effect or Adverse Events?
Als-Nielsen et al.
JAMA 2003;290:921-928.
ABSTRACT | FULL TEXT  

Industry Funding of Clinical Trials: Benefit or Bias?
Chopra
JAMA 2003;290:113-114.
FULL TEXT  

Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman et al.
JAMA 2003;289:454-465.
ABSTRACT | FULL TEXT  

Manuscript Criteria and Information
Arch Gen Psychiatry 2003;60:103-103.
FULL TEXT  

Colloid Use in the Critically Ill
Cook
ANN INTERN MED 2002;137:370-371.
FULL TEXT  

Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
DeMets and Califf
Circulation 2002;106:880-886.
FULL TEXT  

Prevalence of Honorary and Ghost Authorship in Cochrane Reviews
Mowatt et al.
JAMA 2002;287:2769-2771.
ABSTRACT | FULL TEXT  

Association of Journal Quality Indicators With Methodological Quality of Clinical Research Articles
Lee et al.
JAMA 2002;287:2805-2808.
ABSTRACT | FULL TEXT  

Responsibilities of investigators
Sade and McKneally
J. Thorac. Cardiovasc. Surg. 2002;123:837-838.
FULL TEXT  

Responsibilities of investigators
Sade and McKneally
Ann. Thorac. Surg. 2002;73:1364-1365.
FULL TEXT  

Early Toronto experience with new standards for industry-sponsored clinical research: a progress report
Naylor
CMAJ 2002;166:453-456.
FULL TEXT  

New Instructions for Authors: Enhancing Clarity and Accountability for Readers
Glass and Coyle
Arch Gen Psychiatry 2002;59:14-14.
FULL TEXT  

Conflict of interest and the British Journal of Psychiatry Author's reply Response from Neurolink Editor's response
Wright et al.
Br. J. Psychiatry 2002;180:82-83.
FULL TEXT